Macrogenics (MGNX) Reports In-Line Q4 EPS

Macrogenics (NASDAQ: MGNX) reported Q4 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $34.13 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• Logitech dips as BofA downgrades stock on demand outlook concerns
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations